Institut Pasteur Korea

ko en

Natural Antimicrobial
Technology Licensed Out
to Industry

Mechanism of Q203 (Telacebec)
Gains Spotlight as a Core Strategy
for Tuberculosis Treatment

Open Lab facility for industry,
academia, and research
institute - Virus Research
Resource Center (RRC)

Excellent phase 2A results
of Q203 * (Telacebec)
presented at WHO
conference and published in AJRCCM

Development of a Nanoparticle-Based
Platform for Precision Diagnosis and
Targetd Therapy of Latent Tuberculosis

INSTITUT PASTEUR KOREA AT A GLANCE

From Louis Pasteur of the 19th century to Institut Pasteur Korea of today, we are Pasteurians fighting diseases for everyone in the world

Research & Technology
at a Glance Discovery Biology Translational Research Research Infra Center

Areas of Expertise
Fighting Diseases Fostering Collaboration Education & Training

Our Impact
Research & Technology Service Technology & Infrastructure

Technology for All
Pasteur Network Nobel Laureates Legacy of Louis Pasteur

Pasteurians

Stories to Share

Materials to
Learn More About Us